| Literature DB >> 33156594 |
Lauge Hjorth Mikkelsen1,2, Emil Maag3, Mette Klarskov Andersen4, Mogens Kruhøffer3, Ann-Cathrine Larsen1,2, Linea Cecilie Melchior5, Peter Bjerre Toft2, Christian von Buchwald6, Karin Wadt4, Steffen Heegaard1,2.
Abstract
Herein, we wanted to explore the molecular landscape of mucosal melanoma from different sites and identify potential molecular targets for future therapy. Mucosal melanomas (N = 40) from different sites (conjunctiva, sinonasal cavity, rectum, and vagina) were investigated. Targeted next-generation sequencing along with Nanostring gene expression profiling was performed. Genetically, conjunctival melanoma was characterized by BRAF-V600E (30%) and NF1 mutations (17%). Mucosal melanomas at nonsun-exposed sites harbored alterations in NRAS, KIT, NF1, along with atypical BRAF mutations. When comparing the gene expression profile of conjunctival melanoma and nonsun-exposed mucosal melanoma, 41 genes were found to be significantly deregulated. Programmed death-ligand 1 (PD-L1) presented a significant sixfold upregulation in conjunctival melanoma compared to the other mucosal melanomas. While melanomas of the sinonasal cavity, vagina, and rectum are molecularly similar, conjunctival melanoma is characterized by a higher frequency of BRAF-V600E mutations and differential expression of several genes involved in the immune response.Entities:
Mesh:
Year: 2020 PMID: 33156594 DOI: 10.1097/CMR.0000000000000686
Source DB: PubMed Journal: Melanoma Res ISSN: 0960-8931 Impact factor: 3.599